北美肝癌诊断市场预测至 2028 年 - COVID-19 影响和分析 - 按类型（实验室测试、内窥镜检查、成像、活检等）和最终用户（医院和诊断实验室、学术和研究机构、和 CRO 实验室）
No. of Pages: 140 | Report Code: BMIRE00025043 | Category: Life Sciences
No. of Pages: 140 | Report Code: BMIRE00025043 | Category: Life Sciences
准确诊断肝癌进展的能力至关重要用于选择合适的治疗方案。此外，为了满足不断增长的需求，各公司和组织已采取巨大举措来开发和实施创新解决方案，以早期识别这种疾病。例如，2020 年 3 月，罗氏控股公司的 Elecsys GALAD 评分获得美国食品和药物管理局的突破性设备地位，用于早期检测晚期肝癌。这家瑞士制药商的计算器结合了年龄、性别和生物标志物结果等因素来检测早期肝细胞癌，这是最常见的肝癌形式。此外，Elecsys GALAD 评分旨在支持临床医生及时、准确地诊断肝细胞癌。
研发 (R&D) 支出2021年为146.5亿美元，2020年为131.7亿美元。 F. Hoffmann-La Roche Ltd. 的核心研发 (R&D) 支出增长了 14%，主要是由肿瘤学、眼科和个性化医疗保健的后期投资推动的。 2021年，诊断事业部研发投入187892万美元。同样，2019 年 11 月，EXACT Sciences Corporation 因其基于血液的肝癌早期检测检测获得了美国食品和药物管理局 (FDA) 的突破性认定。
此外2020 年 6 月，美国国立卫生研究院 (NIH) 的科学家在美国国家癌症研究所 (NCI) 的研究人员领导下开发了血液检测技术，以帮助改善肝癌筛查。此外，2019年6月，约翰·霍普金斯大学的研究人员设计了液体活检测试CancerSEEK。该测试旨在早期诊断多种癌症，包括胃癌、肝癌、卵巢癌和食管癌，以促进早期治疗。因此，不断增加的研发投资和肝癌诊断测试的开发正在推动肝癌诊断市场的发展。
凭借新的功能和技术，供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会在预测期内推动北美肝癌诊断市场实现大幅复合年增长率。
根据类型、最终用户和国家/地区对北美肝癌诊断市场进行分析。根据类型，市场分为实验室测试、成像、内窥镜检查、活检等。 2021年，实验室测试领域占据最大市场份额，成像领域预计在预测期内将实现更高的复合年增长率。
基于实验室测试，市场分为血液测试和生物标记物。 2021年，血液检测细分市场占据更大的市场份额，预计该细分市场在预测期内的复合年增长率最高。
基于对于最终用户，市场分为医院和诊断实验室、学术和研究机构以及 CRO 实验室。 2021年，医院和诊断实验室细分市场占据最大市场份额，预计该细分市场在预测期内将实现更高的复合年增长率。
基于从国家来看，北美肝癌诊断市场分为美国、加拿大和墨西哥。 2021年，美国占据最大的市场份额，预计在预测期内将以最快的复合年增长率增长。
雅培；生物梅里埃公司； F. 霍夫曼拉罗什有限公司；照明公司；皇家飞利浦公司；凯杰；西门子医疗股份公司；赛默飞世尔科技有限公司；通用电气医疗保健；视角；和 Helio, Inc. 是北美肝癌诊断市场的领先公司。
Strategic insights for North America Liver Cancer Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 3,843.93 Million |
| Market Size by 2028 | US$ 6,666.24 Million |
| Global CAGR (2021 - 2028) | 8.2% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Liver Cancer Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Liver Cancer Diagnostics Market is valued at US$ 3,843.93 Million in 2021, it is projected to reach US$ 6,666.24 Million by 2028.
As per our report North America Liver Cancer Diagnostics Market, the market size is valued at US$ 3,843.93 Million in 2021, projecting it to reach US$ 6,666.24 Million by 2028. This translates to a CAGR of approximately 8.2% during the forecast period.
The North America Liver Cancer Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Liver Cancer Diagnostics Market report:
The North America Liver Cancer Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Liver Cancer Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Liver Cancer Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Liver Cancer Diagnostics Market
